Sangamo Therapeutics
SGMO
$0.51
Share price
2.13%
Change (1 day)
-68.09%
Change (1 year)
Sangamo Therapeutics (SGMO) - Net assets
Net assets on the balance sheet as of December 2023 : $82.88 M
According to Sangamo Therapeutics
's latest financial reports the company has $82.88 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $82.88 M | -71.9% |
| 2022-12-31 | $0.29 B | -21.42% |
| 2021-12-31 | $0.37 B | -24.53% |
| 2020-12-31 | $0.49 B | 14.93% |
| 2019-12-31 | $0.43 B | 17.83% |
| 2018-12-31 | $0.36 B | 95.45% |
| 2017-12-31 | $0.18 B | 37.96% |
| 2016-12-31 | $0.13 B | -29.23% |
| 2015-12-31 | $0.19 B | -6.87% |
| 2014-12-31 | $0.20 B | 69.77% |
| 2013-12-31 | $0.12 B | 87.55% |
| 2012-12-31 | $64.89 M | -19.01% |
| 2011-12-31 | $80.13 M | 43.33% |
| 2010-12-31 | $55.9 M | -22.12% |
| 2009-12-31 | $71.78 M | 29.58% |
| 2008-12-31 | $55.39 M | -23.19% |
| 2007-12-31 | $72.12 M | 48.08% |
| 2006-12-31 | $48.7 M | 28.8% |
| 2005-12-31 | $37.81 M | 16.79% |
| 2004-12-31 | $32.37 M | -27.5% |
| 2003-12-31 | $44.66 M | -17.67% |
| 2002-12-31 | $54.24 M | -34.13% |
| 2001-12-31 | $82.34 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 82,873.20% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 7,418.67% | 🇺🇸 USA |
 Biogen BIIB | $14.79 B | 17,754.91% | 🇺🇸 USA |
 Dow DOW | $19.10 B | 22,953.07% | 🇺🇸 USA |
 Gilead Sciences GILD | $22.74 B | 27,345.80% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 45,305.19% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.23 B | -366.20% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 5,873.86% | 🇺🇸 USA |